Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Epidemiology and Trends of Mortality From Prostate Cancer in Iran



Rafiemanesh H1 ; Enayatrad M2 ; Salehiniya H3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Epidemiology and Biostatistics, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Isfahan Medical School Published:2015

Abstract

Background: Prostate cancer is the second leading cause of death in men and the eighth cause of cancer death in the world. According to state of the disease in Iranian men, it is necessary to understand the epidemiology and trends of deaths from this cancer. This study aimed to investigate the epidemiology of prostate cancer trends of mortality from it in Iran. Methods: In this cross-sectional study, published data were used to relate to the face of death in the Iran. The data of prostate cancer mortality during 2005-2010 were extracted and trends of mortality of this cancer were demonstrated in the Iran. Findings: The death rate from prostate cancer had increased from 2.67 per hundred thousand people in 2005 to 3.24 in 2010. The mortality rates of prostate cancer increased with increasing in age in all the years of the study. Conclusion: Death from prostate cancer in Iran, like other countries in the world, occurs in older men and the mortality rate increases with increasing in age. Trends of mortality from prostate cancer are increasing; changes in recent years are consistent with studies in other Asian countries. Due to the aging of the Iranian population, developing one screening program for men is the way for prevention of prostate cancer progression and reducing mortality of this cancer. © 2015 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics, Asian Pacific Journal of Cancer Prevention (2016)
2. Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends, Asian Pacific Journal of Cancer Prevention (2016)
3. Time Trend Analysis of Cancer Incidence in Caspian Sea, 2004-2009: A Population-Based Cancer Registries Study (Northern Iran), Caspian Journal of Internal Medicine (2016)
4. Relationship Between Perineural Invasion in Prostate Needle Biopsy Specimens and Pathologic Staging After Radical Prostatectomy, Nephro-Urology Monthly (2016)
5. Burden Assessment of Thyroid Cancer in Iran From 1990 to 2010: Lessons Obtained From Global Burden of Disease Report 2010, Asian Pacific Journal of Cancer Prevention (2015)
6. The Trend in Histological Changes and the Incidence of Esophagus Cancer in Iran (2003–2008), International Journal of Preventive Medicine (2016)
7. Human Development Inequality Index and Cancer Pattern: A Global Distributive Study, Asian Pacific Journal of Cancer Prevention (2016)
8. Secondhand Smoking and the Risk of Esophageal Squamous Cell Carcinoma in a High Incidence Region, Kashmir, India: A Case-Control-Observational Study, Medicine (United States) (2016)
Experts (# of related papers)
View all Related Experts
Reza Malekzadeh (4)
Mostafa Hosseini (3)
Other Related Docs
9. Epidemiology Characteristics and Trends of Lung Cancer Incidence in Iran, Asian Pacific Journal of Cancer Prevention (2016)
10. The Prediction Incidence of the Three Most Common Cancers Among Iranian Military Community During 2007-2019: A Time Series Analysis, Journal of Preventive Medicine and Hygiene (2019)
11. Cancer Epidemiology and Trends in North Khorasan Province of Iran, Clinical Epidemiology and Global Health (2018)
12. Cancer Epidemiology and Trends in Sistan and Baluchestan Province, Iran, Medical Journal of the Islamic Republic of Iran (2015)
13. Gender-Age Disparity of Cancers' Incidence in Iran, Acta Medica Iranica (2018)
14. Efficacy of Duloxetine on Electrodiagnostic Findings of Paclitaxel-Induced Peripheral Neuropathy, Does It Have a Prophylactic Effect? a Randomized Clinical Trial, Anti-Cancer Drugs (2023)
15. Incidence and Mortality of Breast Cancer and Their Relationship to Development in Asia, Asian Pacific Journal of Cancer Prevention (2015)
16. Incidence, Mortality, and Epidemiological Aspects of Cancers in Iran; Differences With the World Data, Journal of B.U.ON. (2016)
17. The Comparison of Two Types of Relaxation Techniques on Postoperative State Anxiety in Candidates for the Mastectomy Surgery: A Randomized Controlled Clinical Trial, International Journal of Community Based Nursing and Midwifery (2017)
18. Cancer Incidence in Iran in 2014: Results of the Iranian National Population-Based Cancer Registry, Cancer Epidemiology (2019)
19. The Incidence and Mortality of Kidney Cancers,And Their Relationship With Human Development Index in Asia, Journal of Nephropathology (2017)
20. The Epidemiological and Histological Trend of Bladder Cancer in Iran, Journal of Cancer Research and Therapeutics (2018)
21. Xenotropic Murine Leukemia Virus-Related Virus and Rnase L R462q Variants in Iranian Patients With Sporadic Prostate Cancer, Iranian Red Crescent Medical Journal (2015)
22. Spatial Analysis of Breast Cancer Incidence in Iran, Asian Pacific Journal of Cancer Prevention (2016)
23. Apoptotic Effects of Linum Album Extracts on Ags Human Gastric Adenocarcinoma Cells and Znf703 Oncogene Expression, Asian Pacific Journal of Cancer Prevention (2018)
24. Epidemiological Survey of the Most Prevalent Cancers and Its Association With Other Non-Communicable Diseases Among the Iranian Military Community Between 2001‒2017: A Cross-Sectional Study, Journal of Military Medicine (2019)
25. Trends in Incidence of Common Cancers in Iran, Asian Pacific Journal of Cancer Prevention (2016)
26. The Incidence of Bladder Cancer in Iran: A Systematic Review and Meta-Analysis, World Cancer Research Journal (2019)
27. Incidence and Mortality of Various Cancers in Iran and Compare to Other Countries: A Review Article, Iranian Journal of Public Health (2018)
28. A Systematic Review and Meta-Analysis of the Dna Methylation in Colorectal Cancer Among Iranian Population, Gene Reports (2021)
29. Estimating the Economic Burden of Premature Mortality Caused by Cancer in Iran: 2006-2010, Asian Pacific Journal of Cancer Prevention (2016)
30. Microrna-494 Induces Breast Cancer Cell Apoptosis and Reduces Cell Viability by Inhibition of Nicotinamide Phosphoribosyltransferase Expression and Activity, EXCLI Journal (2019)
31. Botanicals: An Alternative Remedy to Radiotherapy-Induced Dysuria, Complementary Therapies in Medicine (2015)
32. Dietary Total Antioxidant Capacity and Risk of Gastrointestinal Cancers: A Systematic Review and Meta-Analysis of Observational Studies, Archives of Iranian Medicine (2019)
33. Lack of Any Relationship of Stomach Cancer Incidence and Mortality With Development in Asia, Asian Pacific Journal of Cancer Prevention (2016)
34. Gene Panel Testing in Hereditary Breast Cancer, Archives of Iranian Medicine (2020)
35. The Importance of Personalized Medicine in Urological Cancers, Koomesh (2022)
36. Mortality Rate and Years of Life Lost Due to Prostate Cancer in Yazd Province, Iran: A 10-Year Study, Sultan Qaboos University Medical Journal (2017)
37. The Incidence of Lung Cancer and Smoking in Iran, Turkey, England, and the Usa: A Comparative Study, Iranian Rehabilitation Journal (2023)
38. Incidence and Trend of Liver Cancer in Iran, Journal of the College of Physicians and Surgeons Pakistan (2016)
39. Evaluating Long-Term Survival of Patients With Esophageal Cancer Using Parametric Non-Mixture Cure Rate Models, Journal of Advances in Medical and Biomedical Research (2019)
40. Incidence, Trends and Epidemiology of Cancers in North West of Iran, Asian Pacific Journal of Cancer Prevention (2015)
41. Incidence and Mortality of Prostate Cancer and Their Relationship With the Human Development Index Worldwide, Prostate International (2016)
42. The Effects of Nobiletin, Hesperetin, and Letrozole in a Combination on the Activity and Expression of Aromatase in Breast Cancer Cells, Cellular and Molecular Biology (2017)
43. Molecular Expression of Some Oncogenes and Predisposing Behaviors Contributing to the Aggressiveness of Prostate Cancer, Reports of Biochemistry and Molecular Biology (2021)
44. A Review of Incidence and Mortality of Colorectal, Lung, Liver, Thyroid, and Bladder Cancers in Iran and Compared to Other Countries, Wspolczesna Onkologia (2019)
45. Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients With Clinically Localized Prostate Cancer, Nephro-Urology Monthly (2016)
46. Cancer Risk Awareness and Screening Uptake in Individuals at Higher Risk for Colon Cancer: A Cross-Sectional Study, BMJ Open (2016)
47. Gastric Cancer in Iran: An Overview of Risk Factors and Preventive Measures, Archives of Iranian Medicine (2021)
48. Evaluating Long-Term Survival of Patients With Esophageal Cancer Using Parametric Non-Mixture Cure Rate Models, Journal of Zanjan University of Medical Sciences and Health Services (2019)
49. Comparison of the Effects of Nobiletin and Letrozole on the Activity and Expression of Aromatase in the Mcf-7 Breast Cancer Cell Line, Biochemistry and Cell Biology (2017)
50. Clinical Correlation of Mir-200C/141 Cluster Dna Methylation and Mir-141 Expression With the Clinicopathological Features of Colorectal Primary Lesions/Tumors, Reports of Biochemistry and Molecular Biology (2019)